MARKET

MEDP

MEDP

Medpace Holdings
NASDAQ
613.09
+4.20
+0.69%
After Hours: 613.30 +0.21 +0.03% 18:04 01/07 EST
OPEN
610.96
PREV CLOSE
608.89
HIGH
614.36
LOW
599.56
VOLUME
234.26K
TURNOVER
--
52 WEEK HIGH
626.26
52 WEEK LOW
250.05
MARKET CAP
17.27B
P/E (TTM)
42.88
1D
5D
1M
3M
1Y
5Y
1D
Medpace Stock Has Doubled: How Is The Valuation Now?
Seeking Alpha · 14h ago
Here's Why You Should Add PacBio Stock to Your Portfolio
NASDAQ · 18h ago
Is Medpace (MEDP) Using Its 52-Week High Consolidation to Redefine Its Clinical CRO Edge?
Simply Wall St · 19h ago
CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection
NASDAQ · 1d ago
OPKO Health Bets on RAYALDEE and Pipeline Progress for 2026 Growth
NASDAQ · 1d ago
MEDPACE HOLDINGS, INC. TO REPORT FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS ON FEBRUARY 9, 2026
Reuters · 2d ago
Weekly Report: what happened at MEDP last week (1229-0102)?
Weekly Report · 3d ago
INBS Stock Surges 132.4% on New Manufacturing Partnership
NASDAQ · 5d ago
More
About MEDP
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company’s drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company’s operations are principally based in North America, Europe, and Asia.

Webull offers Medpace Holdings Inc stock information, including NASDAQ: MEDP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MEDP stock methods without spending real money on the virtual paper trading platform.